Pennant Group, INC
Market Movers (8-K)
NASDAQ
The Pennant Group, Inc. held its Annual Meeting of Stockholders on May 14, 2026, where directors were elected and the company's independent auditor was ratified.
NASDAQ
The Pennant Group, Inc. announced robust first quarter 2026 financial results, driven by significant revenue growth and improved operational performance across its home health, hospice, and senior living segments.
Better than expected
NASDAQ
The Pennant Group, Inc. announced record-breaking financial and operational results for the fourth quarter and full fiscal year 2025, driven by significant growth in both home health, hospice, and senior living segments.
Better than expected
NASDAQ
The Pennant Group filed an 8-K/A detailing the financial statements and pro forma impact of its recent acquisition of home health and hospice subsidiaries from Amedisys and UnitedHealth.
Better than expected
Capital raise
NASDAQ
The Pennant Group, Inc. announced strong third-quarter 2025 results with record operational metrics and an updated positive full-year guidance, following a major acquisition.
Better than expected
NASDAQ
The Pennant Group, Inc. has expanded its credit facility by $100 million to $350 million, enhancing financial flexibility for future growth.
Better than expected
Capital raise
Quarterly Earnings (10-Q)
NASDAQ
The Pennant Group, Inc. announced a significant increase in revenue for the first quarter of 2026, driven by strong performance in its home health and hospice segment and growth in senior living services.
NASDAQ
The Pennant Group, Inc. announced significant revenue growth in Q3 2025, driven by acquisitions and improved operational performance in both home health and senior living segments, despite a slight dip in quarterly net income.
Delay expected
Worse than expected
Capital raise
NASDAQ
The Pennant Group, Inc. announced significant revenue and net income growth for Q2 2025, driven by strategic acquisitions, while highlighting potential future impacts from proposed Medicare and Medicaid policy changes.
Capital raise
Better than expected
NASDAQ
The Pennant Group's Q1 2025 revenue increased by 33.7% year-over-year, driven by acquisitions and improved performance in both home health and senior living segments.
Better than expected
NASDAQ
The Pennant Group, Inc. saw a significant increase in revenue during the third quarter of 2024, driven by acquisitions and improved performance across its home health, hospice, and senior living segments.
Better than expected
Capital raise
NASDAQ
The Pennant Group saw a significant increase in revenue during the second quarter of 2024, fueled by strategic acquisitions and higher service volumes across its home health, hospice, and senior living segments.
Better than expected
Annual Reports (10-K)
NASDAQ
The Pennant Group, Inc. announced significant revenue and net income growth in 2025, driven by robust organic expansion and strategic acquisitions across its home health, hospice, and senior living segments.
Better than expected
Capital raise
NASDAQ
The Pennant Group, Inc. announces its financial results for the year ended December 31, 2024, showcasing revenue growth driven by organic expansion and strategic acquisitions in home health, hospice, and senior living services.
Better than expected
Capital raise
NASDAQ
The Pennant Group, Inc. saw a 15% revenue increase in 2023, fueled by organic growth across all segments and strategic acquisitions in home health, hospice, and senior living.
Better than expected
Insider Trading (Form 4)
NASDAQ
Barry M Smith, a Director of Pennant Group, Inc., received 1,900 shares of common stock on July 15, 2026.
NASDAQ
Christopher R. Christensen, a Director of Pennant Group, Inc., received 1,900 shares of common stock on July 15, 2026.
NASDAQ
Suzanne D. Snapper, a Director of Pennant Group, Inc., received 1,900 shares of common stock on July 15, 2026.
NASDAQ
John G. Nackel, a Director of Pennant Group, Inc., received 1,900 shares of common stock on July 15, 2026.
NASDAQ
Gregory K Morris Sr., a Director of Pennant Group, Inc., received 1,900 shares of common stock on July 15, 2026.
NASDAQ
Scott E Lamb, a Director of Pennant Group, Inc., received 2,400 shares of common stock on July 15, 2026.
Proxy Statements (Def-14A)
NASDAQ
Pennant Group issues an amendment to its proxy statement to clarify the voting requirement for Proposal 2 regarding the amended certificate of incorporation.
NASDAQ
Pennant Group issues an amendment to its proxy statement to clarify the voting requirement for Proposal 2 regarding the amended certificate of incorporation.
NASDAQ
The Pennant Group is holding its annual meeting on May 16, 2025, to vote on director elections, officer exculpation, an amended incentive plan, auditor ratification, and executive compensation.
NASDAQ
The Pennant Group will hold its annual meeting of stockholders on May 23, 2024, to vote on the election of directors, ratification of the company's accounting firm, and an advisory vote on executive compensation.
Schedule 13G - Passive Investments
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 1,742,207 shares, representing 5.01% of the outstanding common stock of Pennant Group Inc/The.
NASDAQ
Wasatch Advisors LP has reported beneficial ownership of 5.4% of Pennant Group Inc/The's common stock as of June 30, 2026.
NASDAQ
The Vanguard Group has updated its Schedule 13G filing for Pennant Group Inc., reporting 0% beneficial ownership following an internal realignment.
NASDAQ
Van Berkom & Associates Inc. filed an amended Schedule 13G for Pennant Group, Inc., correcting a prior disclosure regarding its 9.01% beneficial ownership.
NASDAQ
8 Knots Management, LLC and Scott Green have reported a combined beneficial ownership of 5.04% of The Pennant Group, Inc.'s common stock in an amended Schedule 13G filing.
NASDAQ
Van Berkom & Associates Inc. has filed an amended Schedule 13G, reporting zero beneficial ownership in Pennant Group, Inc. common shares as of September 30, 2025.
Worse than expected